In view of these facts and other observations that modification of the ECM can affect the growth of both normal and cancerous mammary epithelial cells and the processes of angiogenesis and tumor metastasis [20-22], we speculated that TG2 expression in the stroma of the host can affect breast cancer progression. Here, TGM2 is linked to breast cancer.